Young Health Programme
Currently, an estimated 38 million people die each year from non-communicable diseases (NCDs), such as cardiovascular disease, cancer and diabetes. In most regions, NCDs have emerged as the leading cause of death and disability and NCD-related deaths are increasing, especially in low and middle-income countries.
Launched in 2010, AstraZeneca’s Young Health Programme (YHP) has a unique focus on young people and the prevention of the most common NCDs, such as Type 2 diabetes, cancer, and heart and respiratory disease.
Working with over 30 expert organisations and combining on-the-ground programmes, research and advocacy, YHP targets the risk behaviours, such as tobacco use, alcohol abuse and unhealthy eating, that can lead to these diseases in adulthood. A particular focus is placed on working with marginalised young people.
Since 2010, we have reached over 1.2 million young people in 18 countries, across five continents. We have also achieved our Clinton Global Initiative Commitment to Action of reaching 500,000 young people directly and indirectly with information regarding NCD prevention.
Over 9,500 young people have been trained to share health information with their peers and the community and over 10,000 frontline health providers have been trained in adolescent health, so supporting the sustainability of YHP activities.
Find out more on the AstraZeneca Young Health Programme website.